CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ReSearch Pharmaceutical Services, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ReSearch Pharmaceutical Services, Inc.
520 Virginia Drive
Phone: 215.540.0700p:215.540.0700 Fort Washington, PA  19034  United States Fax: 215.540.0770f:215.540.0770
This company was Merged or Acquired on 9/24/2013.
This company ceased filing statements with the SEC on 2/18/2011.
This is a Subsidiary, click here for the Parent Company
Business Summary
Research Pharmaceutical Services, Inc. is engaged in providing a range of integrated clinical development solutions and services to the bio-pharmaceutical industry clients, including clinical trial project management, site management and study monitoring, patient enrolment, data collection and management, statistical analysis and report writing, quality assurance, and regulatory and medical affairs services. The services support the design, initiation and management of client’s clinical trial programs. It has performed services in connection with trials in many therapeutic areas, including cardiovascular, oncology, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology, obstetrics/gynecology, orthopedics, pediatrics and psychiatry. RPS has wholly owned subsidiaries in the United States, Argentina, Brazil, Canada, Chile, Columbia, Mexico, Peru and Uruguay. In July 2009, the Company completed the acquisition of Paramax International Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201012/31/2009YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Van-ChingYang
President, Chief Executive Officer, Secretary, Director Dennis M.Smith

Business Names
Business Name
Paramax International Inc.
PHC RPS Ukraine
ReSearch Pharmaceutical Services, LLC
42 additional Business Names available in full report.

General Information
Outstanding Shares: 37,264,215 (As of 11/5/2010)
Shareholders: 101
Stock Exchange: LON
Federal Tax Id: 204322769
Fax Number: 215.540.0770


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023